Ardea Biosciences Announces Exercise in Full of Overallotment Option for

SAN DIEGO, Feb. 23, 2011 /PRNewswire/ — Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase an additional 412500
See all stories on this topic »